Skip to content

The Use of Armeo Spring in Upper Extremity Rehabilitation

The Use of Armeo Spring in Upper Extremity Rehabilitation

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02636205
Enrollment
15
Registered
2015-12-21
Start date
2014-07-31
Completion date
2016-12-31
Last updated
2016-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Hemiplegia, Upper Extremity Weakness

Brief summary

The purpose of this study is to evaluate the use of the Armeo®Spring Pediatric as therapy for children with hand and arm weakness. The Armeo®Spring Pediatric is a device that supports the weight of the child's arm and uses joystick that helps to play computer games. The child will be assessed before and after this therapy. Participating children with upper extremity impairments will receive therapy 3x/week for 6 weeks during 30-45 minutes sessions at progressively increasing degrees of difficulty. Each child's performance will be tracked with regard to time necessary to complete a predetermined number of trials of the activity. The standardized assessment tools that will be used are the Assisting Hand Assessment (AHA), Box & Blocks test, Jebsen Taylor hand function test, and the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). Data will be analyzed to determine the efficacy of this training method.

Detailed description

8\. Adverse Events All serious adverse events will be reported to the IRB immediately, but no later than \[5\] days of the occurrence or receipt of notification from an outside source; the IRB can make changes to the consent form as a result of adverse events. Any such event will be reported to the IRB on the Adverse Event Report. \[See attachment.\] 9. Debriefing Debriefing is not required because there is no deception of subjects involved or there are no alternative treatments or procedures used in a blind fashion. 10\. Intervention Participants in this study are children who present with a diagnosis of upper extremity weakness or involvement secondary to various reasons. These children receive occupational, physical, and/or speech services at St Mary's Hospital for Children. The children participating in this program will be receiving their occupational therapy session with the use of the Armeo®Spring Pediatric. They will also continue to receive their regular physical and speech therapy session. Once the program is completed, they will continue to receive their regular occupation therapy sessions. 11\. Confidentiality Data sheets will be coded with a number to represent each child. The numeric data obtained regarding timed trials will be entered into a computer which is password-protected at St. Mary's Hospital for Children in Bayside, NY. Consent forms with the child's name and parental signatures and video tape or photographic images recorded during data collection will be stored in accordance with St. Mary's Hospital for Children patient privacy policy.

Interventions

DEVICEArmeo therapy

Participants will receive 18 sessionsx30 mins of ArmeoSpring therapy over 6weeks.

Sponsors

St Mary's Hospital for Children
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Age between 7 -17 years. * Arm weakness secondary to various causes. * Armeo®Spring Pediatric fit * Upper arm measures:155mm-235mm (7 to 9.5 inches) * Lower arm measures: 230mm-370mm (9inches to 14 inches) * Ability to follow instructions.

Exclusion criteria

* Vision deficits * Contractures that do not allow use of system. * Spasticity that does not allow use of system. * Osteopenia * Recent surgeries to the involved upper extremity.

Design outcomes

Primary

MeasureTime frameDescription
Change in hand functionbaseline and completion (6-8 weeks)Box and Blocks test
Change in bimanual hand functionbaseline and completion (6-8 weeks)Assisting hand Assessment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026